Clinical Trial Update: Efficacy and Safety Study on Menatetrenone in the Treatment of Postmenopausal Osteoporosis Women [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of menatetrenone for postmenopausal osteoporosis has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• Menatetrenone (menatetrenone)

Snippet

Sponsor: Eisai Co., Ltd. | Conditions: Postmenopausal Osteoporosis | Phase 3 | Status: COMPLETED | Results posted: 2011-08-11